baber/WOPTO huggingface dataset:
Patent NZ-309122-A (NZ)
Title: DNA sequences encoding 2 genes that are sex determining on the Z and W chromosomes of birds as well as nucleic acid fragments, proteins, polypeptides, antibodies and related products are provided
Inventor: GRIFFITHS RICHARD
IPC: C12Q1/6879
Filed: 1996-06-05
Abstract: The application provides for DNA sequences (introns and exons) encoding two genes located on the Z and W chromosomes of birds (the avian CHD gene).  These genes can be used to identify the sex of most birds (Class Aves) . In addition, the genes control the sex of the birds, a genetic process which is initiated as an embryo.  Nucleic acid fragments, proteins, polypeptides, antibodies and related products and their use in medicine and agriculture are provided.  The DNA sequences may be used in sex identification or for controlling the sex of adults or the progeny of commercially important animals.
Patent NZ-315994-A (NZ)
Title: Apparatus including a heating resistance mounted in a coupling and a water vapour permeable membrane in a housing
Inventor: ANTHONY JEAN-MICHEL
IPC: A61M16/14
Filed: 1996-08-28
Abstract: PCT No. PCT/BE96/00090 Sec. 371 Date Jan. 12, 1999 Sec. 102(e) Date Jan. 12, 1998 PCT Filed Aug. 29, 1996 PCT Pub. No. WO97/07845 PCT Pub. Date Mar. 6, 1997An apparatus for compensating heat and humidity loss in a device that administers or restitutes air to a patient, amongst others in a device that comprises an air supply duct which extends between a respirator or an anaesthesia apparatus and the patient. The apparatus includes a housing with a coupling to be connected on this air supply duct, in which coupling a heating resistance is mounted, in which housing water is admitted. Further included in the housing is a membrane with water impermeable but water vapor permeable characteristics and an element that assures the desired heat level, in the coupling and air supply duct.
Patent NZ-331337-A (NZ)
Title: Optical switch of cascaded active branch and directional couplers
Inventor: CASTOLDI ANDREA
IPC: G02B6/35
Filed: 1998-08-13
Abstract: n integrated optical switch includes first and second directional couplers 110, 112 having respective pairs of waveguides106, 110 and 108, 112.  An input guide 102 is connected via the branching guide 104 to the respective guides 106 and 108.  A control structure utilizing thermal or electrical field elements 116, 118, 122, 124 is connected to the directional couplers and the waveguides and is operable when energized to select between first and second operating states of the switch.  The first state simultaneously enhances transmission of optical energy from the input guide through the branching guide to the guide 106 and inhibits the transmission of light to the guide 108.  In the first state, no light transmitted to guide 106 is diverted to guide 110, and any light that sneaks into guide 108 is diverted into the guide 112.  The second state transfers the light from the input to the guide 108 and inhibits transmission of light into the guide 106.  In the second state, light transmitted into the guide 108 is not diverted into the guide 112 and light that sneaks into the guide 106 is diverted into the guide 110.
Patent NZ-505902-A (NZ)
Title: Oxazolidinone compounds useful as antimicrobial agents and combinatorial libraries
Inventor: GORDEEV MIKHAIL F
IPC: A61K31/427
Filed: 1999-01-22
Abstract: A method for the solid phase synthesis of oxazolidinones comprises: attaching an olefin to a solid support; oxidizing the olefin to provide an epoxide functionality; opening the epoxide with an amine to form a amino alcohol and cyclizing the amino alcohol, using a phosgene equivalent. An antimicrobial compound has the formula (1) wherein: R3 is aryl or heteroaryl; R20 is -(CH2)m-C(R22)=C(R23)R24 or -(CH2)m-CºCR25; m is 0 to 3; R22, R23 and R24 is H, alkyl, heteroalkyl, aryl or heteroaryl provided at least is heteroalkyl, aryl or heteroaryl and R25 is H, alkyl, heteroalkyl, aryl or heteroaryl.
Patent NZ-507449-A (NZ)
Title: Glucocorticoid receptor antagonists for the treatment of dementia
Inventor: SCHATZBERG ALAN F
IPC: A61K31/569
Filed: 1998-10-05
Abstract: Mifepristone, a potent glucocorticoid receptor antagonist that can be used in methods for treating dementia is disclosed. A kit for treating dementia in a human including a glucocorticoid receptor antagonist and instructional material teaching the indications, dosage and schedule of administration of the glucocorticoid receptor antagonist is also disclosed.
Patent NZ-507458-A (NZ)
Title: Cyano-indole serotonin-reuptake inhibitor compound
Inventor: LAVIELLE GILBERT
IPC: C07D487/04
Filed: 2000-10-11
Abstract: The cyano indoles or their enantiomers, diastereoisomers, and their salts with acids and bases have the formula (I) wherein: R1 and R2 are independently H or alkyl; T1 and T2 are independently alkylene; G is a heterocyclic group of formula (a) or (b) with at least one heteroatom being present and the dotted lines indicate optional double bonds; W1, W2 and W3 are independently nitrogen, CR5, NR4 or CO; W4 is nitrogen, CR3, NR4, or CO; W5 is carbon or nitrogen; X1 is a bond, nitrogen, CR3 or NR4; X2, X3 and X4 are independently CR3, NR4, CO, SR4, SO2, O, S, or N; R3 is H, halogen, alkyl, OH, perhaloalkyl, NO2 or an optionally substituted amino; R4 is H, alkyl, or optionally substituted aryl or aralkyl and R5 is a group R3 or two adjacent groups R5 form, together with the carbon atoms to which they are attached, a saturated or unsaturated mono- or bicyclic group that may contain 1-5 O, N, or S hetero atoms and which may be substituted by R3 or oxo. A pharmaceutical composition thereof is useful as a serotonin-reuptake inhibitor and can be used to treat depression, phobias, impulsive disorders, anxiety and obsessive compulsive disorders.
Patent NZ-508004-A (NZ)
Title: 30 kDa moraxella catarrhalis antigenic proteins
Inventor: KYD JENNELLE
IPC: A61K39/00
Filed: 1999-05-11
Abstract: Disclosed are antigens of B. catarrhalis, together with their use in vaccines as well as methods of diagnosis and/or detection. Such antigens have an apparent molecular mass of about 30 kDa, as determined by SDS-PAGE, and have the following N-terminal sequence: NVVTNTGATVVDGTRTIFSTLVKPAAVVAAV. Antigenic fragments of the protein, nucleic acids encoding the protein, vectors comprising the nucleic acid and host cells transformed with the vector are also disclosed.
Patent NZ-521732-A (NZ)
Title: Production of recombinant blood clotting factors in human cell lines and factor VIII muteins
Inventor: HAUSER CHARLOTTE
IPC: C12N5/08
Filed: 2001-03-21
Abstract: A factor VIII mutein in which the B-domain between positions Arg740 and Glu has been replaced by an Arg-rich linker peptide having at least 3 Arg residues and comprising 10-25 amino acid residues is described, wherein the factor VIII numbering is relative to the mature wild-type factor VIII sequence of SEQ ID NO:2. Also described is a DNA sequence encoding the factor VIII mutein, vectors and host cells, and method of producing the factor VIII mutein. The mutein or gene transfer vector can be used for preparing a pharmaceutical for treating hemophilia A.
Patent NZ-522678-A (NZ)
Title: Method for cheese production in which a lactic acid bacterial starter culture is added to the cheese curd after its preparing
Inventor: ANDERSEN KIM TOFT
IPC: A23C19/06
Filed: 2001-04-27
Abstract: A method for making cheese is described. The method involves the preparation of a cheese curd using a curdling agent wherein a lactic acid bacterial starter culture is introduced into the resulting cheese curd. The advantage of the present method is that is possible to produce a large amount of cheese curd which may subsequently be divided into smaller portions each of which can be inoculated with specific and designed lactic acid bacterial starter culture to obtain different types of cheese or different ripening profile (storage time) for the same cheese type. Thus, this method is useful in the manufacturing of a variety of cheese types originating from a single curd.
Patent NZ-524277-A (NZ)
Title: Genes and proteins, and their uses
Inventor: LANE JONATHAN DOUGLAS
IPC: A61K48/00
Filed: 2001-08-21
Abstract: A series of genes from Neisseria meningitidis that are suitable for encoding products which are targets for immunization are disclosed. The identification of these genes therefore allows vaccines to be produced and other therapeutic products. In particular, the disclosure relates to pho2-10 (accession number NMB0749 ) putative penicillin-binding protein 4.
Patent NZ-524969-A (NZ)
Title: Biodegradable molded articles, process for producing the smae and compositions for foam molding
Inventor: OZASA AKIO
IPC: B32B9/02
Filed: 2001-09-12
Abstract: A biodegradable molded article comprising: a biodegradable expanded molded article molded in a specified shape; and a coating film attached on a surface of the biodegradable expanded molded article, wherein the biodegradable expanded molded article is mainly made of starch or a derivative thereof and molded through steam expansion of a slurry or dough molding material prepared by adding water to the starch or the derivative thereof, and the coating film is mainly made of a biodegradable plastic and having at least hydrophobicity.
Patent NZ-528796-A (NZ)
Title: Method and system for sharing personal health data and providing authentication to a health care provider to access selected items of the data
Inventor: DEMIRIAN VASKEN
IPC: G16H20/10
Filed: 2002-03-14
Abstract: A method for a health care provider to obtain personal health data relating to a consumer, comprises: the consumer causing personal health data to be stored in a secure repository, the repository requiring authentication of the consumer's identity before the consumer is provided access to the repository; the consumer selecting items of personal health data to share and identifying a health care provider, or class of health care providers, to whom access will be provided for those items of personal health data; a health care provider providing authentication of their identity to the consumer's secure repository and being provided access to those items of personal health data of the consumer for which the health care provider has been identified for sharing; the health care provider using the personal health data of the consumer to determine health care advice or the provision of a health care service for the consumer; and the health care provider recording details of the consultation and the advice or service provided to the consumer in the secure repository of health data of the consumer.
Patent NZ-530015-A (NZ)
Title: Method of prompting audience members in an audience identification system
Inventor: DONATO PAUL
IPC: H04N17/00
Filed: 2002-06-14
Abstract: A method of prompting an audience member to enter an audience member identification into an audience meter comprises: determining a probability that the audience member is in an audience of a receiver; prompting the audience member to enter the audience member identification if the probability that the audience member is in the audience of the receiver is less than a threshold; and suppressing prompting of the audience member if the probability that the audience member is in the audience of the receiver is greater than the threshold. A method of prompting an audience member to enter an audience member identification into an audience meter comprises: determining a variable as a function of a number of times that the audience member was in an audience of a receiver and a number of times that the receiver was turned on; determining a probability that the audience member is in an audience of a receiver based upon tuning style; prompting the audience member to enter the audience member identification if the variable is not greater than a first threshold and if the probability is not greater than a second threshold; and suppressing prompting of the audience member if the variable is greater than the threshold and if the probability is greater than a second threshold.
Patent NZ-530721-A (NZ)
Title: Cysteine mutants and methods for detecting ligand binding to biological molecules
Inventor: MCDOWELL ROBERT S
IPC: G06F19/00
Filed: 2002-08-05
Abstract: A set of variant proteins wherein each protein is a mutated version of a target biological molecule (TBM) such as a cytokine, a kinase or selected from a specific group.. A naturally occurring non-cysteine residue of the TBM is mutated into a cysteine.
Patent NZ-540530-A (NZ)
Title: Method for making a fiber glass and cellulose mat in cationic medium
Inventor: DROUX MICHEL
IPC: D21H13/40
Filed: 2004-01-07
Abstract: A method for preparing a mat containing glass fibers and cellulose fibers is disclosed, which comprises: a step which consists in dispersing in process water chopped glass fibers and cellulose fibers, followed by a step which consists in forming a bed in a forming device by passing the dispersion on a forming fabric through which the process water is drained, the fibers being retained on said fabric, said dispersion comprising at the time of said passage cationic process water; then a step which consists in a heat treatment in an oven or stoving device. Said method enables in particular the production of a web comprising 2 to 12 % of cellulose, 70 to 80 % of glass, 8 to 27 % of binder whereof the tear strength is higher than 430 gf as measured by the ISO 1974 standard.
Patent NZ-548290-A (NZ)
Title: Notification system
Inventor: MERRY ALAN FORBES
IPC: G16H50/30
Filed: 2006-12-30
Abstract: A notification apparatus comprising a processor and a signalling means is provided. The processor is adapted to receive variable physiological data from a subject and determine whether the data has increased or decreased beyond one or more predetermined threshold values a predetermined number of times during a predetermined interval. The signalling means is adapted to indicate at least one event or action is required, including at least the administration of an antibiotic, heparin or protamine.
Patent NZ-549247-A (NZ)
Title: Animal lifting and supporting means
Inventor: BORRIE DONALD ROBERT
Filed: 2006-08-18
Abstract: A device (1) for raising and supporting a quadruped animal in an upright position is disclosed. The device has a frame comprised of elongate members (2a-c) that meet at an apex (3), a means (13) for engaging and supporting the animal, such as a hip clamp, hip lifter, or cow sling, and lifting means (10c) capable of raising and lowering the engaging means.
Patent NZ-552071-A (NZ)
Title: Erasure detection and power control for a transmission without error detection coding
Inventor: AGRAWAL AVNEESH
IPC: H04B7/005
Filed: 2005-06-07
Abstract: An apparatus for performing power control in a communication system comprises: means for receiving a codeword via a first wireless link; means for computing an indication of confidence that the received codeword is correct where the indication is based on a determination of the Euclidean distance between the received codeword and each of a set of possible valid codeword; means for generating a message to adjust a power of the communication system based on whether the computed indication of confidence was within an erasure threshold; and means for transmitting said message on second wireless link.
Patent NZ-553489-A (NZ)
Title: Method for producing highly textured, strip-shaped, high-temperature superconductors
Inventor: BACKER MICHAEL
IPC: C04B35/50
Filed: 2005-08-05
Abstract: Disclosed is a process for the production of a band-shaped high temperature superconductor that consists of a metal substrate, at least one buffer layer and a high temperature superconductor layer that is located on the buffer layer, the latter consisting of yttrium-stabilized zirconium oxide, gadolinium zirconate, yttrium oxide, lanthanum aluminate, lanthanum zirconate, strontium titanate, nickel oxide, cerium oxide, magnesium oxide, lanthanum manganate, or strontium ruthenate, comprising the steps of: (a) production of a coating solution that contains a polar solvent with at least one free hydroxyl group, (b) application of the coating solution to the metal substrate, (c) drying, (d) production of the buffer layer by annealing treatment, and (e) application of a high temperature superconductor layer on the buffer layer, characterized in that propionic acid is used as a polar solvent with at least one free hydroxyl group.
Patent NZ-562940-A (NZ)
Title: Beta-2 adrenoceptor agonists for treating connective tissue diseases of the skin
Inventor: WEIDNER MORTEN SLOTH
IPC: A61P37/00
Filed: 2006-04-12
Abstract: Disclosed is the use of a beta2-adrenoceptor agonist of formula I, or a stereoisomer or pharmaceutically acceptable salt thereof, wherein the substituents are as defined in the specification, and the carbon atom 1 is in the R-configuration, for local, topical treatment of cutaneous forms of lupus erythematosus chosen from subacute cutaneous lupus erythematosus, chronic cutaneous lupus erythematosus, discoid lupus erythematosus, lupus panniculitis, and lupus erythematosus profundus. Also disclosed is a dermatologically administrable pharmaceutical composition comprising 0.05-5% w/w of a compound of formula I as defined above.
Patent NZ-567889-A (NZ)
Title: Sterilizing compositions comprising orthophthalaldehyde and non-ionic surfactants
Inventor: WHITELEY REGINALD KEITH
IPC: A01N25/30
Filed: 2008-03-28
Abstract: Disclosed is a sterilizing composition including: (i) at least one aromatic dialdehyde such as 1,2-diformylbenzene (also known as ortho-phthalic dicarboxaldehyde, benzene-1,2-dicarboxaldehyde, orthophthalaldehyde and phthaldialdehyde); (ii) at least one glycol or polyol or derivative thereof; (iii) a first non-ionic surfactant; and (iv) a second surfactant having a cloud point in the range of about 30°C to 50°C and selected from the group consisting of an ethoxylated propoxylated C8-C10 alcohol; a branched chain chlorine capped ethylene oxide; and a polyoxyethylene polyoxypropylene block copolymer. Further disclosed is a method of destruction and/or removal of a surgical soil from a reusable surgical appliance or equipment, ancillary fibre optic or electronic accessory, which method includes treating the surgical appliance, ancillary fibre optic or electronic accessory with a composition as defined above.
Patent NZ-573845-A (NZ)
Title: Preserved slices of vegetables and fruits and processing methods
Inventor: ERLE ULRICH
IPC: A23L19/00
Filed: 2006-07-12
Abstract: Provided is a method of preparing a dehydrated slice of a vegetable or a fruit, the method comprising the steps of: - cutting a vegetable or fruit in a plurality of slices, - heat-treating said slices by one or more water-based heating methods selected from the group consisting of blanching, boiling and steaming, - contacting said slices with carbohydrate, which is a non-reducing disaccharide, either during or after the heat-treating step to provide carbohydrate uptake by the slices and/or a coating of the surface of said slices, - pre-drying said heat-treated slices, wherein each slice is placed on an air-permeable surface such that the slices do not overlap each other, and wherein the slices contact said air-permeable surface such that a shrinking of the circumference is substantially prevented, and - final air drying, whereby a dehydrated slice is obtained, said dehydrated slice comprising; - a circumference being substantially the same as a circumference of the respective slice of the raw vegetable or fruit; - a thickness reduced by 20 to 95 % in comparison to the thickness of the respective slice of the raw vegetable or fruit, and having a planar surface, - a coloured peel or skin and said peel or skin is not visibly discoloured in comparison to the peel or skin colour of the respective raw vegetable or the raw fruit, and - adapted to be rehydrated by a rehydration process.
Patent NZ-584370-A (NZ)
Title: Processes for the preparation of paliperidone and pharmaceutically acceptable salts thereof and intermediates for use in the processes
Inventor: KANKAN RAJENDRA NARAYANRAO
IPC: A61K31/519
Filed: 2008-10-09
Abstract: Disclosed is a process for preparing paliperidone or a salt thereof comprising: (1) (a) condensing a 3-benzyloxy-2-aminopyridine (II) with an alpha-acyl lactone (V) in the presence of a catalytic amount of a dipolar aprotic solvent and an activating agent to obtain a compound of formula (III); (b) condensing the compound of formula (III) with a compound of formula (VI) or a salt thereof to obtain the compound of formula (VIII); (c) converting the compound of formula (VIII) to paliperidone by catalytic reduction; and (d) optionally converting paliperidone to a salt thereof; (2) (a) condensing a 3-benzyloxy-2-aminopyridine (II) with an alpha-acyl lactone (V) in the presence of a catalytic amount of a dipolar aprotic solvent and an activating agent to obtain a compound of formula (III); (b) catalytically reducing the compound of formula (III) to a compound of formula (IV) in the presence of an acid; (c) condensing chloroethyl derivative (IV) with compound (VI) or a salt thereof in the presence of a base to obtain paliperidone (I); and (d) optionally converting paliperidone to a salt thereof; or (3) (a) condensing a 3-benzyloxy-2-aminopyridine derivative (II) with an alpha-acyl lactone (V) in the presence of a catalytic amount of a dipolar aprotic solvent and an activating agent to obtain a compound of formula (III); (b) condensing the compound of formula (III) with a compound of formula (IX) to obtain a compound of formula (X); (c) converting the compound (X) to a compound of formula (XI) by catalytic reduction and cyclising the compound (XI) to obtain paliperidone; (d) and optionally converting paliperidone to a salt thereof.
Patent NZ-585144-A (NZ)
Title: Dual locking band clamp having a threaded buckle for interconnection to a band and method of locking it
Inventor: DORNEMAN CASEY JAMES
IPC: B21D22/04
Filed: 2008-11-03
Abstract: The disclosure is directed to a locked band clamp, comprising: a buckle including an opening therethrough for receiving a band, said buckle also including an aperture through an outer surface of said buckle for receiving a punch; a band positioned within said buckle; a deformation formed in the band located generally adjacent to said aperture, said deformation preventing relative motion between said band and said buckle; a curled portion of said band that engages an edge of said outer surface of said buckle that prevents relative motion of said buckle relative to said band; and a visual indicator formed in the band at least partially around said deformation. These band clamps are generally useful constraining or supporting or securing signage, lights or other objects onto poles.
Patent NZ-585460-A (NZ)
Title: Inhibitors of human phosphatidyl-inositol 3-kinase delta
Inventor: WHITE STEPHEN L
IPC: C07D403/08
Filed: 2008-11-12
Abstract: 585460 Disclosed is a compound of formula (I).
Patent NZ-586221-A (NZ)
Title: Dosing regimen associated with long acting injectable paliperidone esters
Inventor: VERMEULEN AN MARGRIET CORNELIA
IPC: A61P25/18
Filed: 2008-12-17
Abstract: Disclosed is the use of paliperidone palmitate in the treatment of psychosis, schizophrenia, bipolar disorder, or other mental disorder according to a dosing regimen comprising: a) administering intramuscularly in the deltoid of a patient a first loading dose of from about 100 mg-eq. to about 150 mg-eq. of paliperidone palmitate formulated in a sustained release formulation on the first day of treatment; b) administering intramuscularly in the deltoid muscle of the patient in need of treatment a second loading dose of from about 100 mg-eq. to about 150 mg-eq. of paliperidone palmitate formulated in a sustained release formulation on the 6th to about 10th day of treatment; and c) administering intramuscularly in the deltoid or gluteal muscle of the patient in need of treatment a maintenance dose of about 25 mg-eq. to about 150 mg-eq. of paliperidone palmitate in a sustained release formulation on about the 34th to about the 38th day of treatment.